Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | KDM1A | O60341 | 1/20 | 0.32 |
| ▸ | PER2 | O15055 | 1/20 | 0.32 |
| ▸ | CRY1 | Q16526 | 1/20 | 0.32 |
| ▸ | CRY2 | Q49AN0 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.31 |
| ▸ | HTT | P42858 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HBB | P68871 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22742619 | 0.94 | CYP1A2 (0.34) | CYP1A2CYP3A4CYP2C19KDM1A | |
| SCHEMBL22741235 | 0.92 | PER2 (0.33) | CYP1A2CYP3A4CYP2C19KDM1APER2 | |
| SCHEMBL22740728 | 0.89 | CYP1A2 (0.33) | CYP1A2CYP3A4CYP2C19KDM1APER2 | |
| SCHEMBL22742797 | 0.89 | CYP1A2 (0.34) | CYP1A2CYP3A4CYP2C19KDM1APER2 | |
| SCHEMBL22742800 | 0.87 | KDM1A (0.39) | CYP1A2CYP3A4CYP2C19KDM1APER2 | |
| SCHEMBL22742799 | 0.86 | KDM4E (0.41) | KDM1AHPGDMAPK1HTTKDM4E | |
| SCHEMBL22742755 | 0.85 | KDM4E (0.33) | KDM4E | |
| SCHEMBL22740460 | 0.83 | CYP1A2 (0.34) | CYP1A2CYP3A4CYP2C19KDM1A | |
| SCHEMBL22740351 | 0.81 | KDM1A (0.41) | CYP1A2CYP3A4CYP2C19KDM1APER2 | |
| SCHEMBL22740495 | 0.80 | SIGMAR1 (0.33) | CYP1A2CYP3A4CYP2C19HPGDMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200377513-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2020-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200377513-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | PIEZO1, TMEM109, LEF1 | CYP1A2 1206/4885CYP3A4 793/4885CYP2C19 183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.